Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2022-03-30
Product name
TRIUMEQ DISPERSIBLE TABLET, 5 MG/60 MG/30 MG
Product Synonyms
TRIUMEQ PD (ABACAVIR, DOLUTEGRAVIR, AND LAMIVUDINE) TABLETS FOR ORAL SUSPENSION, 60MG/5MG/30MG * TRIUMEQ CAPSULE SHAPED, BICONVEX, FILM-COATED TABLETS *
1.2.2. Uses advised against
No other uses are advised Details of principal suppliers
Manufacturer Name
ViiV
Icons in SDS
Company Information
company name
ViiV
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Serious eye damage or eye irritation Category 1 Skin sensitisation Category 1 Germ cell mutagenicity Category 2 Carcinogenicity Category 1B Reproductive toxicity Category 2
Environmental hazards
Hazardous to the aquatic environment - chronic Category 3
Signal word
Danger
Hazard statements
May cause allergic skin reaction. Causes serious eye damage. Suspected of causing genetic defects. May cause cancer. Suspected of damaging fertility or the unborn child. Harmful to aquatic life with long lasting effects.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Avoid breathing dust/fume/gas/mist/vapours/spray. Contaminated work clothing shall not be allowed out of the workplace. Avoid release to the environment. Wear eye protection/face protection. Wear protective gloves. Use personal protective equipment as required.
Response
IF ON SKIN Wash with plenty of soap and water. IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTRE or doctor/physician. Specific treatment (see instructions on this label). If skin irritation or rash occurs: Get medical advice/attention. Wash contaminated clothing before reuse.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Potent pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
57.3702 % of the mixture consists of component(s) of unknown acute oral toxicity. 92.6272 % of the mixture consists of component(s) of unknown acute dermal toxicity. 82.5328 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 57.3363 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. Section 3: Composition and information of the ingredients of the hazardous chemical
